SyntheticMR announced today that their quantitative imaging software solution SyMRi has received regulatory approval in both Saudi Arabia and Thailand.

'We are delighted to be able to introduce SyMRI to both Saudi Arabia and Thailand,' says Ulrik Harrysson, CEO, SyntheticMR. 'This further develops the global presence of SyntheticMR and follows regulatory clearance for SyMRI in Japan and Brazil, both of which were confirmed during 2020.'

SyMRI provides multiple contrast weighted images and quantitative information about the patient in a single 5-6 minute scan, enabling users to speed up their imaging workflow and add objective decision support to their practice. SyMRI is the first product on the market to provide segmentation and measurements of myelin volumes. The volume measurements in SyMRI NEURO offer unique capabilities to track a patient's development and compare values.

Attachments

  • Original document
  • Permalink

Disclaimer

SyntheticMR AB published this content on 21 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 September 2020 16:14:07 UTC